Sumitomo Pharma Co., Ltd. (DNPUF)
8.405
0.00 (0.00%)
USD |
OTCM |
Aug 24, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.770B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -6.30% |
| Valuation | |
| PE Ratio | 4.489 |
| PE Ratio (Forward) | |
| PS Ratio | 1.112 |
| Price to Book Value | 1.500 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.3932 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 90.98% |
Profile
| Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the following geographical segments: Japan, North America and Asia. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan. |
| URL | https://www.sumitomo-pharma.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 30, 2026 |
| Last Earnings Release | Jul. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 30, 2023 |
Profile
| Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the following geographical segments: Japan, North America and Asia. The company was founded on May 14, 1897 and is headquartered in Osaka, Japan. |
| URL | https://www.sumitomo-pharma.co.jp |
| Investor Relations URL | N/A |
| HQ State/Province | Osaka |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Value |
| Next Earnings Release | Oct. 30, 2026 |
| Last Earnings Release | Jul. 31, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 30, 2023 |